VACCINS ANTI-GRIPPE 2026
AI summary
This tender concerns the supply of influenza vaccines for 2026. GAPAM is seeking qualified suppliers to provide flu vaccines in the required quantities and formulations to meet anticipated demand for the upcoming influenza season.
Pharmaceutical suppliers or authorized vaccine distributors with demonstrated experience in influenza vaccine supply and regulatory compliance in France should bid.
Suppliers must be authorized to distribute pharmaceutical products, particularly vaccines, and comply with all regulatory requirements for vaccine manufacturing and supply. Documentation of quality certifications and cold-chain management capabilities is essential.
Frequently asked questions
What is this tender about?
This tender concerns the supply of influenza vaccines for 2026. GAPAM is seeking qualified suppliers to provide flu vaccines in the required quantities and formulations to meet anticipated demand for the upcoming influenza season.
What are the requirements for suppliers?
Suppliers must be authorized to distribute pharmaceutical products, particularly vaccines, and comply with all regulatory requirements for vaccine manufacturing and supply. Documentation of quality certifications and cold-chain management capabilities is essential.
What type of company should bid?
Pharmaceutical suppliers or authorized vaccine distributors with demonstrated experience in influenza vaccine supply and regulatory compliance in France should bid.
Who is the buyer?
The buyer is GAPAM.
When does this tender close?
Submissions close on April 24, 2026.
Description not provided
Documents not listed
Products & services not specified
Scoring criteria not specified
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…